The rising interest in potent weight management has led to considerable investigation into groundbreaking treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has exhibited positive results in medical trials, suggesting potential for significant weight reduction . Con